Drug intelligence / Profile preview

influenza nasal spray vaccine (virus-vectored)

Development stage
Approved
Lead developer
WANTAI BioPharm
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
Administration
Intranasal
01

Overview

This influenza nasal spray vaccine is a live attenuated influenza virus-vectored candidate developed by Xiamen Wan Tai (Beijing Wantai Biological Pharmacy). Designed for intranasal administration, the vaccine utilizes a live attenuated influenza virus platform to express specific influenza antigens. This approach is intended to stimulate both mucosal and systemic immune responses, mimicking natural infection to provide broad protection against influenza. The vaccine is currently in the preclinical stage of development, leveraging the same viral vector technology used in the company's approved COVID-19 nasal spray vaccine.

Other names
Influenza Nasal Spray VaccineVirus-vectored influenza intranasal vaccine

Beyond the preview

Go deeper on influenza nasal spray vaccine (virus-vectored).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on influenza nasal spray vaccine (virus-vectored).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call